Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Qiagen
QGEN
$8.54B
| $1.7M | ﹤0.01% |
35,643
-1,134
| -3% | -$54.7K |
|
2602
Kodiak Sciences
KOD
$2.6B
| $1.69M | ﹤0.01% |
245,096
-457
| -0.2% | -$2.79K |
|
2603
Ivanhoe Electric
IE
$1.45B
| $1.68M | ﹤0.01% |
128,765
+23,784
| +23% | +$301K |
|
|
TEN
2604
Tsakos Energy Navigation Ltd
TEN
$1.21B
| $1.67M | ﹤0.01% |
93,544
+50,203
| +116% | +$881K |
|
2605
Powell Industries
POWL
$7.6B
| $1.66M | ﹤0.01% |
82,356
+3,870
| +5% | +$67K |
|
|
AMRS
2606
DELISTED
Amyris Inc.
AMRS
| $1.66M | ﹤0.01% |
1,607,680
-185,478
| -10% | -$173K |
|
2607
Codexis
CDXS
$151M
| $1.64M | ﹤0.01% |
587,403
-44,667
| -7% | -$144K |
|
2608
ProKidney
PROK
$316M
| $1.64M | ﹤0.01% |
+146,782
| New | +$1.56M |
|
|
MAXN
2609
DELISTED
Maxeon Solar Technologies
MAXN
| $1.64M | ﹤0.01% |
+583
| New | +$1.67M |
|
2610
Nano X Imaging
NNOX
$68.2M
| $1.64M | ﹤0.01% |
105,899
+2,144
| +2% | +$29.7K |
|
2611
Traeger
COOK
$178M
| $1.64M | ﹤0.01% |
7,700
+172
| +2% | +$31.1K |
|
2612
Mineralys Therapeutics
MLYS
$2.25B
| $1.63M | ﹤0.01% |
95,691
+6,731
| +8% | +$101K |
|
2613
Lexicon Pharmaceuticals
LXRX
$1.03B
| $1.63M | ﹤0.01% |
712,375
+23,764
| +3% | +$63.1K |
|
|
BELFB
2614
Bel Fuse Inc Class B
BELFB
$3.87B
| $1.63M | ﹤0.01% |
+28,400
| New | +$1.3M |
|
2615
Teekay
TK
$1.01B
| $1.63M | ﹤0.01% |
269,355
-38,673
| -13% | -$226K |
|
2616
PMV Pharmaceuticals
PMVP
$59.2M
| $1.63M | ﹤0.01% |
259,842
+6,368
| +3% | +$33.4K |
|
2617
BlackSky Technology
BKSY
$943M
| $1.63M | ﹤0.01% |
91,518
+45,563
| +99% | +$544K |
|
2618
Harrow
HROW
$1.45B
| $1.62M | ﹤0.01% |
84,948
+38,918
| +85% | +$856K |
|
2619
Cricut
CRCT
$984M
| $1.61M | ﹤0.01% |
131,709
+113,330
| +617% | +$1.24M |
|
2620
Advantage Solutions
ADV
$522M
| $1.61M | ﹤0.01% |
27,466
+650
| +2% | +$27.8K |
|
2621
Erasca
ERAS
$6.3B
| $1.6M | ﹤0.01% |
580,698
+31,610
| +6% | +$90K |
|
2622
Holley
HLLY
$321M
| $1.6M | ﹤0.01% |
391,743
+14,285
| +4% | +$42.6K |
|
2623
Tactile Systems Technology
TCMD
$635M
| $1.59M | ﹤0.01% |
63,894
+11,802
| +23% | +$245K |
|
|
PTRA
2624
DELISTED
Proterra Inc. Common Stock
PTRA
| $1.59M | ﹤0.01% |
1,322,831
-190,605
| -13% | -$234K |
|
2625
Cardlytics
CDLX
$21.7M
| $1.59M | ﹤0.01% |
25,086
+680
| +3% | +$41.2K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.